• Something wrong with this record ?

Hypothermic Ex Situ Perfusion of Human Limbs With Acellular Solution for 24 Hours

V. Haug, B. Kollar, S. Tasigiorgos, Y. Endo, M. Kauke, AF. Safi, A. Veeramani, O. Abdulrazzak, B. Bausk, D. Walt, B. Pomahac,

. 2020 ; 104 (9) : e260-e270. [pub] -

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Machine perfusion (MP) has evolved as a promising approach for the ex situ preservation in organ transplantation. However, the literature on the use of MP in human vascularized composite allografts is scarce. The aim of this study was to evaluate the effects of hypothermic MP with an acellular perfusate in human upper extremities and compare with the current gold standard of static cold storage (SCS). METHODS: Six upper extremities were assigned to either MP (n = 3) or SCS (n = 3) conditions for 24 h. MP-extremities were perfused with oxygenated Steen solution at a constant pressure of 30 mm Hg and 10°C. RESULTS: Median total ischemia time was 213 min (range, 127-222 min). Myoglobin, creatine-kinase (CK) showed increased levels at the start of MP (medians: myoglobin: 4377 ng/mL, CK: 1442 U/L), peaking 6 h after perfusate exchange (medians: myoglobin: 9206 ng/mL, CK: 3995 U/L) at timepoint 24. Lactate levels decreased from a median of 6.9-2.8 mmol/L over time. Expression of hypoxia-inducible factor 1-alpha peaked in the SCS-group after 8 h, followed by a decrease. Increased hypoxia-inducible factor 1-alpha expression in the MP group was delayed until 20 h. Perfusion pressure, temperature, and circuit flow were maintained at median of 30.88 mm Hg, 9.77°C, and 31.13 mL/min, respectively. Weight increased 1.4% in the SCS group and 4.3% in the MP group over 24 h. CONCLUSIONS: Hypothermic ex situ perfusion with an oxygenated acellular Steen solution may extend the allowable extracorporeal preservation time by a factor of 4-6 compared to SCS and holds promise to be beneficial for vascularized composite allograft recipients and victims of traumatic major limb amputation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21001325
003      
CZ-PrNML
005      
20210119110838.0
007      
ta
008      
210119s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/TP.0000000000003221 $2 doi
035    __
$a (PubMed)32168040
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Haug, Valentin $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, Germany.
245    10
$a Hypothermic Ex Situ Perfusion of Human Limbs With Acellular Solution for 24 Hours / $c V. Haug, B. Kollar, S. Tasigiorgos, Y. Endo, M. Kauke, AF. Safi, A. Veeramani, O. Abdulrazzak, B. Bausk, D. Walt, B. Pomahac,
520    9_
$a BACKGROUND: Machine perfusion (MP) has evolved as a promising approach for the ex situ preservation in organ transplantation. However, the literature on the use of MP in human vascularized composite allografts is scarce. The aim of this study was to evaluate the effects of hypothermic MP with an acellular perfusate in human upper extremities and compare with the current gold standard of static cold storage (SCS). METHODS: Six upper extremities were assigned to either MP (n = 3) or SCS (n = 3) conditions for 24 h. MP-extremities were perfused with oxygenated Steen solution at a constant pressure of 30 mm Hg and 10°C. RESULTS: Median total ischemia time was 213 min (range, 127-222 min). Myoglobin, creatine-kinase (CK) showed increased levels at the start of MP (medians: myoglobin: 4377 ng/mL, CK: 1442 U/L), peaking 6 h after perfusate exchange (medians: myoglobin: 9206 ng/mL, CK: 3995 U/L) at timepoint 24. Lactate levels decreased from a median of 6.9-2.8 mmol/L over time. Expression of hypoxia-inducible factor 1-alpha peaked in the SCS-group after 8 h, followed by a decrease. Increased hypoxia-inducible factor 1-alpha expression in the MP group was delayed until 20 h. Perfusion pressure, temperature, and circuit flow were maintained at median of 30.88 mm Hg, 9.77°C, and 31.13 mL/min, respectively. Weight increased 1.4% in the SCS group and 4.3% in the MP group over 24 h. CONCLUSIONS: Hypothermic ex situ perfusion with an oxygenated acellular Steen solution may extend the allowable extracorporeal preservation time by a factor of 4-6 compared to SCS and holds promise to be beneficial for vascularized composite allograft recipients and victims of traumatic major limb amputation.
650    _2
$a dospělí $7 D000328
650    _2
$a alografty $7 D064591
650    _2
$a nízká teplota $7 D003080
650    _2
$a cytokiny $x analýza $7 D016207
650    _2
$a končetiny $x krevní zásobení $x chirurgie $7 D005121
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a uchovávání orgánů $x metody $7 D009926
650    _2
$a roztoky pro uchovávání orgánů $7 D019188
650    _2
$a perfuze $x metody $7 D010477
650    _2
$a replantace $x metody $7 D012092
650    _2
$a teplá ischemie $7 D052096
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kollar, Branislav $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Tasigiorgos, Sotirios $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Endo, Yori $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Kauke, Martin $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Safi, Ali-Farid $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Veeramani, Anamika $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Abdulrazzak, Obada $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
700    1_
$a Bausk, Bruce $u Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Wyss Institute for Bioinspired Engineering at Harvard University, Boston, MA.
700    1_
$a Walt, David $u Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Wyss Institute for Bioinspired Engineering at Harvard University, Boston, MA.
700    1_
$a Pomahač, Bohdan, $u Division of Plastic Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. $d 1971- $7 xx0117402
773    0_
$w MED00010695 $t Transplantation $x 1534-6080 $g Roč. 104, č. 9 (2020), s. e260-e270
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32168040 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210119 $b ABA008
991    __
$a 20210119110835 $b ABA008
999    __
$a ok $b bmc $g 1611146 $s 1121608
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 104 $c 9 $d e260-e270 $e - $i 1534-6080 $m Transplantation $n Transplantation $x MED00010695
LZP    __
$a Pubmed-20210119

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...